VivoSim Labs, Inc. Restricted Cash and Cash Equivalents, Noncurrent
VivoSim Labs, Inc. (VIVS) had Restricted Cash and Cash Equivalents, Noncurrent of $100.00 thousand as of 2026-03-31, per its 10-K filed 2026-07-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Cash Equivalent, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2026-07-14
- 2026-03-31: Restricted Cash and Cash Equivalents, Noncurrent $100.00K.
- 2025-03-31: Restricted Cash and Cash Equivalents, Noncurrent $100.00K.
- 2024-03-31: Restricted Cash and Cash Equivalents, Noncurrent $100.00K.
- 2023-03-31: Restricted Cash and Cash Equivalents, Noncurrent $100.00K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent | Restricted Cash and Cash Equivalents, Noncurrent as first filed |
|---|---|---|
| 2026-03-31 | $100.00K 10-K · filed 2026-07-14 | |
| 2025-03-31 | $100.00K 10-K · filed 2026-07-14 | |
| 2024-03-31 | $100.00K 10-K · filed 2025-06-05 | |
| 2023-03-31 | $100.00K 10-K · filed 2024-05-31 | |
| 2022-03-31 | $100.00K 10-K · filed 2023-07-14 | |
| 2021-03-31 | $100.00K 10-K · filed 2022-06-10 | |
| 2020-03-31 | $0.00 10-K · filed 2021-06-15 | |
| 2019-03-31 | $79.00K 10-K · filed 2020-05-28 | |
| 2018-09-30 | $127.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $127.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $127.00K 10-K · filed 2019-06-03 | |
| 2017-12-31 | $127.00K 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $127.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $127.00K 10-Q · filed 2018-08-09 | |
| 2017-03-31 | $127.00K 10-K · filed 2018-05-31 | |
| 2016-12-31 | $127.00K 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $79.00K 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $79.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $79.00K 10-K · filed 2017-06-07 | |
| 2015-12-31 | $79.00K 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $78.80K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $78.80K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $79.00K 10-K · filed 2016-06-09 | $78.80K 10-K · filed 2015-06-09 |
| 2014-03-31 | $78.80K 10-K · filed 2015-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |